Variables | Relapse | 5 year-DFS% | p valuea | p valueb | HR(95%CI) | |
---|---|---|---|---|---|---|
Yes | No | |||||
Type of surgery | 0.423 | |||||
RS (reference) | 9 | 47 | 83.0 | |||
FSS | 5 | 47 | 91.0 | |||
Age | 0.106 | |||||
≤ 30 years (reference) | 4 | 51 | 91.7 | |||
> 30 years | 10 | 43 | 81.9 | |||
Tumor size | 0.878 | |||||
≤ 12 cm (reference) | 7 | 48 | 88.0 | |||
> 12 cm | 7 | 46 | 85.2 | |||
Histology | 0.467 | |||||
Mucinous | 4 | 48 | 91.5 | |||
Serous | 1 | 8 | 88.9 | |||
Endometrioid | 5 | 22 | 83.1 | |||
CCC (reference) | 4 | 16 | 78.5 | |||
Grade | 0.006 | 0.048 | 3.41(1.01–11.49) | |||
G1-2 (reference) | 7 | 77 | 92.0 | |||
G3/CCC | 7 | 17 | 68.6 | |||
FIGO stage | 0.053 | |||||
IA-B (reference) | 1 | 35 | 97.2 | |||
IC1 | 9 | 46 | 83.9 | 0.199 | 4.03(0.48–33.87) | |
IC2-3 | 4 | 13 | 70.6 | 0.325 | 3.35(0.30–37.41) | |
Pretreatment tumor markers | 0.071 | 0.075 | 3.30(0.89–12.29) | |||
Normal (reference) | 4 | 51 | 92.2 | |||
Elevated | 10 | 43 | 80.9 | |||
EAOC | 0.002 | 0.092 | 2.56(0.86–7.63) | |||
No (reference) | 7 | 80 | 91.5 | |||
Yes | 7 | 14 | 67.3 |